TREEFROG PRESENTS DATA FROM THEIR PARKINSON’S CELL THERAPY PROGRAM AT THE AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING

Posted on by

TreeFrog Therapeutics reports on the first bioproduction of a cell therapy for Parkinson’s Disease in a scalable bioreactor1 BORDEAUX, France, April 15, 2024 /PRNewswire/ — TreeFrog Therapeutics, a cell therapy development company with its lead program in Parkinson’s Disease is…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.